Annovis Bio Inc (ANVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,427 | -17,606 | -28,854 | -19,020 | -11,757 |
| Accounts payable and accrued liabilities | 737 | 2,685 | 285 | -194 | -1,332 |
| Other Working Capital | 965 | 8,680 | 1,579 | 1,324 | -2,026 |
| Other Operating Activity | -199 | -2,770 | 1,371 | 1,197 | 1,910 |
| Operating Cash Flow | $-30,925 | $-9,012 | $-25,620 | $-16,693 | $-13,205 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 30,122 | 3,698 | 34,600 | 21,427 | 19,783 |
| Financing Cash Flow | $30,122 | $3,698 | $34,600 | $21,427 | $19,783 |
| Beginning Cash Position | 19,532 | 19,532 | 10,552 | 10,552 | 10,552 |
| End Cash Position | 18,729 | 14,219 | 19,532 | 15,286 | 17,130 |
| Net Cash Flow | $-803 | $-5,313 | $8,980 | $4,735 | $6,578 |
| Free Cash Flow | |||||
| Operating Cash Flow | -30,925 | -9,012 | -25,620 | -16,693 | -13,205 |
| Free Cash Flow | -30,925 | -9,012 | -25,620 | -16,693 | -13,205 |